Talk to us?

- NEETMDS- courses
NEET MDS Lessons
Periodontology

Periodontal Medications and Their Uses

Periodontal medications play a crucial role in the management of periodontal diseases, aiding in the treatment of infections, inflammation, and tissue regeneration. Understanding the various types of medications and their specific uses is essential for effective periodontal therapy.

Types of Periodontal Medications

  1. Antibiotics:

    • Uses:
      • Used to treat bacterial infections associated with periodontal disease.
      • Commonly prescribed antibiotics include amoxicillin, metronidazole, and doxycycline.
    • Mechanism:
      • They help reduce the bacterial load in periodontal pockets, promoting healing and reducing inflammation.
  2. Antimicrobial Agents:

    • Chlorhexidine:
      • Uses: A topical antiseptic used as a mouth rinse to reduce plaque and gingivitis.
      • Mechanism: It disrupts bacterial cell membranes and inhibits bacterial growth.
    • Tetracycline:
      • Uses: Can be used topically in periodontal pockets to reduce bacteria.
      • Mechanism: Inhibits protein synthesis in bacteria, reducing their ability to cause infection.
  3. Anti-Inflammatory Medications:

    • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs):
      • Uses: Used to manage pain and inflammation associated with periodontal disease.
      • Examples: Ibuprofen and naproxen.
    • Corticosteroids:
      • Uses: May be used in severe cases to reduce inflammation.
      • Mechanism: Suppress the immune response and reduce inflammation.
  4. Local Delivery Systems:

    • Doxycycline Gel (Atridox):
      • Uses: A biodegradable gel that releases doxycycline directly into periodontal pockets.
      • Mechanism: Provides localized antibiotic therapy to reduce bacteria and inflammation.
    • Minocycline Microspheres (Arestin):
      • Uses: A localized antibiotic treatment that is placed directly into periodontal pockets.
      • Mechanism: Releases minocycline over time to combat infection.
  5. Regenerative Agents:

    • Bone Grafts and Guided Tissue Regeneration (GTR) Materials:
      • Uses: Used in surgical procedures to promote the regeneration of lost periodontal tissues.
      • Mechanism: Provide a scaffold for new tissue growth and prevent the ingrowth of epithelium into the defect.
  6. Desensitizing Agents:

    • Fluoride Varnishes:
      • Uses: Applied to sensitive areas to reduce sensitivity and promote remineralization.
      • Mechanism: Strengthens enamel and reduces sensitivity by occluding dentinal tubules.

Clinical Significance of Periodontal Medications

  1. Management of Periodontal Disease:

    • Medications are essential in controlling infections and inflammation, which are critical for the successful treatment of periodontal diseases.
  2. Adjunct to Non-Surgical Therapy:

    • Periodontal medications can enhance the effectiveness of non-surgical treatments, such as scaling and root planing, by reducing bacterial load and inflammation.
  3. Surgical Interventions:

    • In surgical procedures, medications can aid in healing and regeneration, improving outcomes for patients undergoing periodontal surgery.
  4. Patient Compliance:

    • Educating patients about the importance of medications in their treatment plan can improve compliance and overall treatment success.

Influence of Host Response on Periodontal Disease

The host response plays a critical role in the progression and management of periodontal disease. Various host factors influence bacterial colonization, invasion, tissue destruction, and healing processes. Understanding these interactions is essential for developing effective treatment strategies.

Aspects of Periodontal Disease and Host Factors

  1. Bacterial Colonization:

    • Host Factor: Antibody C in crevicular fluid.
    • Mechanism:
      • Antibody C inhibits the adherence and coaggregation of bacteria in the subgingival environment.
      • This action potentially reduces bacterial numbers by promoting lysis (destruction of bacterial cells).
    • Implication: A robust antibody response can help control the initial colonization of pathogenic bacteria, thereby influencing the onset of periodontal disease.
  2. Bacterial Invasion:

    • Host Factor: Antibody C-mediated lysis and neutrophil activity.
    • Mechanism:
      • Antibody C-mediated lysis reduces bacterial counts in the periodontal tissues.
      • Neutrophils, through processes such as chemotaxis (movement towards chemical signals), phagocytosis (engulfing and digesting bacteria), and lysis, further reduce bacterial counts.
    • Implication: An effective neutrophil response is crucial for controlling bacterial invasion and preventing the progression of periodontal disease.
  3. Tissue Destruction:

    • Host Factors: Antibody-mediated hypersensitivity and cell-mediated immune responses.
    • Mechanism:
      • Activation of tissue factors, such as collagenase, leads to the breakdown of connective tissue and periodontal structures.
      • The immune response can inadvertently contribute to tissue destruction, as inflammatory mediators can damage host tissues.
    • Implication: While the immune response is essential for fighting infection, it can also lead to collateral damage in periodontal tissues, exacerbating disease progression.
  4. Healing and Fibrosis:

    • Host Factors: Lymphocytes and macrophage-produced chemotactic factors.
    • Mechanism:
      • Lymphocytes and macrophages release chemotactic factors that attract fibroblasts to the site of injury.
      • Fibroblasts are activated by specific factors, promoting tissue repair and fibrosis (the formation of excess connective tissue).
    • Implication: A balanced immune response is necessary for effective healing and regeneration of periodontal tissues following inflammation.

Periodontal Medicaments

Periodontal diseases often require adjunctive therapies to traditional mechanical treatments such as scaling and root planing. Various medicaments have been developed to enhance the healing process and control infection in periodontal tissues. This lecture will discuss several periodontal medicaments, their compositions, and their clinical applications.

1. Elyzol

  • Composition:
    • Elyzol is an oil-based gel containing 25% metronidazole. It is formulated with glyceryl mono-oleate and sesame oil.
  • Clinical Use:
    • Elyzol has been found to be equivalent to scaling and root planing in terms of effectiveness for treating periodontal disease.
    • However, no adjunctive effects beyond those achieved with mechanical debridement have been demonstrated.

2. Actisite

  • Composition:

    • Actisite consists of tetracycline-containing fibers.
    • Each fiber has a diameter of 0.5 mm and contains 12.7 mg of tetracycline per 9 inches of fiber.
  • Clinical Use:

    • The fibers are placed directly into periodontal pockets, where they release tetracycline over time, helping to reduce bacterial load and promote healing.

3. Arestin

  • Composition:

    • Arestin contains minocycline, which is delivered as a biodegradable powder in a syringe.
  • Clinical Use:

    • Arestin is indicated for the treatment of periodontal disease and is applied directly into periodontal pockets, where it provides localized antibiotic therapy.

4. Atridox

  • Composition:

    • Atridox contains 10% doxycycline in a syringeable gel system that is biodegradable.
  • Clinical Use:

    • The gel is injected into periodontal pockets, where it solidifies and releases doxycycline over time, aiding in the management of periodontal disease.

5. Dentamycin and Periocline

  • Composition:

    • Both Dentamycin and Periocline contain 2% minocycline hydrochloride.
  • Clinical Use:

    • These products are used similarly to other local delivery systems, providing localized antibiotic therapy to reduce bacterial infection in periodontal pockets.

6. Periochip

  • Composition:

    • Periochip is a biodegradable chip that contains chlorhexidine.
  • Clinical Use:

    • The chip is placed in the gingival crevice, where it releases chlorhexidine over time, providing antimicrobial action and helping to control periodontal disease.

Sutures for Periodontal Flaps

Suturing is a critical aspect of periodontal surgery, particularly when managing periodontal flaps. The choice of suture material can significantly influence healing, tissue adaptation, and overall surgical outcomes.

1. Nonabsorbable Sutures

Nonabsorbable sutures are designed to remain in the tissue until they are manually removed. They are often used in situations where long-term support is needed.

A. Types of Nonabsorbable Sutures

  1. Silk (Braided)

    • Characteristics:
      • Excellent handling properties and knot security.
      • Provides good tissue approximation.
    • Applications: Commonly used in periodontal surgeries due to its ease of use and reliability.
  2. Nylon (Monofilament) (Ethilon)

    • Characteristics:
      • Strong and resistant to stretching.
      • Less tissue reactivity compared to silk.
    • Applications: Ideal for delicate tissues and areas requiring minimal tissue trauma.
  3. ePTFE (Monofilament) (Gore-Tex)

    • Characteristics:
      • Biocompatible and non-reactive.
      • Excellent tensile strength and flexibility.
    • Applications: Often used in guided tissue regeneration procedures and in areas where long-term support is needed.
  4. Polyester (Braided) (Ethibond)

    • Characteristics:
      • High tensile strength and good knot security.
      • Less pliable than silk.
    • Applications: Used in situations requiring strong sutures, such as in flap stabilization.

2. Absorbable Sutures

Absorbable sutures are designed to be broken down by the body over time, eliminating the need for removal. They are often used in periodontal surgeries where temporary support is sufficient.

A. Types of Absorbable Sutures

  1. Surgical Gut

    • Plain Gut (Monofilament)

      • Absorption Time: Approximately 30 days.
      • Characteristics: Made from sheep or cow intestines; provides good tensile strength initially but loses strength quickly.
      • Applications: Suitable for soft tissue approximation where rapid absorption is desired.
    • Chromic Gut (Monofilament)

      • Absorption Time: Approximately 45 to 60 days.
      • Characteristics: Treated with chromium salts to delay absorption; retains strength longer than plain gut.
      • Applications: Used in areas where a longer healing time is expected.
  2. Synthetic Absorbable Sutures

    • Polyglycolic Acid (Braided) (Vicryl, Ethicon)

      • Absorption Time: Approximately 16 to 20 days.
      • Characteristics: Provides good tensile strength and is absorbed predictably.
      • Applications: Commonly used in periodontal and oral surgeries due to its handling properties.
    • Dexon (Davis & Geck)

      • Characteristics: Similar to Vicryl; made from polyglycolic acid.
      • Applications: Used in soft tissue approximation and ligation.
    • Polyglycaprone (Monofilament) (Maxon)

      • Absorption Time: Similar to Vicryl.
      • Characteristics: Offers excellent tensile strength and is absorbed more slowly than other synthetic options.
      • Applications: Ideal for areas requiring longer support during healing.

Aggressive Periodontitis (formerly Juvenile Periodontitis)

  • Historical Names: Previously referred to as periodontosis, deep cementopathia, diseases of eruption, Gottleib’s diseases, and periodontitis marginalis progressive.
  • Risk Factors:
    • High frequency of Actinobacillus actinomycetemcomitans.
    • Immune defects (functional defects of PMNs and monocytes).
    • Autoimmunity and genetic factors.
    • Environmental factors, including smoking.
  • Clinical Features:
    • Vertical loss of alveolar bone around the first molars and incisors, typically beginning around puberty.
    • Bone loss patterns often described as "target" or "bull" shaped lesions.

Dental Calculus

Dental calculus, also known as tartar, is a hard deposit that forms on teeth due to the mineralization of dental plaque. Understanding the composition and crystal forms of calculus is essential for dental professionals in diagnosing and managing periodontal disease.

Crystal Forms in Dental Calculus

  1. Common Crystal Forms:

    • Dental calculus typically contains two or more crystal forms. The most frequently detected forms include:
      • Hydroxyapatite:
        • This is the primary mineral component of both enamel and calculus, constituting a significant portion of the calculus sample.
        • Hydroxyapatite is a crystalline structure that provides strength and stability to the calculus.
      • Octacalcium Phosphate:
        • Detected in a high percentage of supragingival calculus samples (97% to 100%).
        • This form is also a significant contributor to the bulk of calculus.
  2. Other Crystal Forms:

    • Brushite:
      • More commonly found in the mandibular anterior region of the mouth.
      • Brushite is a less stable form of calcium phosphate and may indicate a younger calculus deposit.
    • Magnesium Whitlockite:
      • Typically found in the posterior areas of the mouth.
      • This form may be associated with older calculus deposits and can indicate changes in the mineral composition over time.
  3. Variation with Age:

    • The incidence and types of crystal forms present in calculus can vary with the age of the deposit.
    • Younger calculus deposits may have a higher proportion of brushite, while older deposits may show a predominance of hydroxyapatite and magnesium whitlockite.

Clinical Significance

  1. Understanding Calculus Formation:

    • Knowledge of the crystal forms in calculus can help dental professionals understand the mineralization process and the conditions under which calculus forms.
  2. Implications for Treatment:

    • The composition of calculus can influence treatment strategies. For example, older calculus deposits may be more difficult to remove due to their hardness and mineral content.
  3. Assessment of Periodontal Health:

    • The presence and type of calculus can provide insights into a patient’s oral hygiene practices and periodontal health. Regular monitoring and removal of calculus are essential for preventing periodontal disease.
  4. Research and Development:

    • Understanding the mineral composition of calculus can aid in the development of new dental materials and treatments aimed at preventing calculus formation and promoting oral health.

Periodontal Bone Grafts

Bone grafting is a critical procedure in periodontal surgery, aimed at restoring lost bone and supporting the regeneration of periodontal tissues.

1. Bone Blend

 Bone blend is a mixture of cortical or cancellous bone that is procured using a trephine or rongeurs, placed in an amalgam capsule, and triturated to achieve a slushy osseous mass. This technique allows for the creation of smaller particle sizes, which enhances resorption and replacement with host bone.

Particle Size: The ideal particle size for bone blend is approximately 210 x 105 micrometers.

Rationale: Smaller particle sizes improve the chances of resorption and integration with the host bone, making the graft more effective.

2. Types of Periodontal Bone Grafts

A. Autogenous Grafts

Autogenous grafts are harvested from the patient’s own body, providing the best compatibility and healing potential.

  1. Cortical Bone Chips

    • History: First used by Nabers and O'Leary in 1965.
    • Characteristics: Composed of shavings of cortical bone removed during osteoplasty and ostectomy from intraoral sites.
    • Challenges: Larger particle sizes can complicate placement and handling, and there is a potential for sequestration. This method has largely been replaced by autogenous osseous coagulum and bone blend.
  2. Osseous Coagulum and Bone Blend

    • Technique: Intraoral bone is obtained using high- or low-speed round burs and mixed with blood to form an osseous coagulum (Robinson, 1969).
    • Advantages: Overcomes disadvantages of cortical bone chips, such as inability to aspirate during collection and variability in quality and quantity of collected bone.
    • Applications: Used in various periodontal procedures to enhance healing and regeneration.
  3. Intraoral Cancellous Bone and Marrow

    • Sources: Healing bony wounds, extraction sockets, edentulous ridges, mandibular retromolar areas, and maxillary tuberosity.
    • Applications: Provides a rich source of osteogenic cells and growth factors for bone regeneration.
  4. Extraoral Cancellous Bone and Marrow

    • Sources: Obtained from the anterior or posterior iliac crest.
    • Advantages: Generally offers the greatest potential for new bone growth due to the abundance of cancellous bone and marrow.

B. Bone Allografts

Bone allografts are harvested from donors and can be classified into three main types:

  1. Undermineralized Freeze-Dried Bone Allograft (FDBA)

    • Introduction: Introduced in 1976 by Mellonig et al.
    • Process: Freeze drying removes approximately 95% of the water from bone, preserving morphology, solubility, and chemical integrity while reducing antigenicity.
    • Efficacy: FDBA combined with autogenous bone is more effective than FDBA alone, particularly in treating furcation involvements.
  2. Demineralized (Decalcified) FDBA

    • Mechanism: Demineralization enhances osteogenic potential by exposing bone morphogenetic proteins (BMPs) in the bone matrix.
    • Osteoinduction vs. Osteoconduction: Demineralized grafts induce new bone formation (osteoinduction), while undermineralized allografts facilitate bone growth by providing a scaffold (osteoconduction).
  3. Frozen Iliac Cancellous Bone and Marrow

    • Usage: Used sparingly due to variability in outcomes and potential complications.

Comparison of Allografts and Alloplasts

  • Clinical Outcomes: Both FDBA and DFDBA have been compared to porous particulate hydroxyapatite, showing little difference in post-treatment clinical parameters.
  • Histological Healing: Grafts of DFDBA typically heal with regeneration of the periodontium, while synthetic bone grafts (alloplasts) heal by repair, which may not restore the original periodontal architecture.

Explore by Exams